NEWS: Curebase closes $40M Series B with strategic investment by Gilead. Read about it in TechCrunch, Fierce Biotech, andEndpoints News.

2800+
patients
prescreened/mo1
17
DTx studies
97%
patient
satisfaction2
1. In fully virtual cancer well-being PDT study 2. From IBS PDT study
All-in-one solution

Remote-first DTx research powered by technology

Expand geographic access with Curebase’s virtual sites powered by purpose-built software for better retention and easier monitoring on studies running for months to years.

2800+
patients
prescreened/mo1
17
DTx studies
97%
patient
satisfaction2
1. In fully virtual cancer well-being PDT study 2. From IBS PDT study
All-in-one solution

Remote-first DTx research powered by technology

Curebase has the most experience running end-to-end, regulatory-grade digital therapeutics (DTx) studies with purpose-built technology for faster recruitment, better retention, and greater diversity.

2800+
patients
prescreened/mo1
17
DTx studies
97%
patient
satisfaction2
1. In fully virtual cancer well-being PDT study 2. From IBS PDT study
All-in-one solution

Remote-first DTx research powered by technology

Curebase is the only partner you need to run your study from start to finish with purpose-built technology for faster recruitment, greater diversity, and better patient experience.

Modern, flexible long-term follow-up research.
All-in-one solution

Fast, flexible end-to-end diagnostic studies

Expand geographic access with Curebase’s virtual sites powered by purpose-built software for better retention and easier monitoring on studies running for months to years.

Remote-first Digital Therapeutics DTx research powered by technology
All-in-one solution

Fast, flexible end-to-end diagnostic studies

Curebase has the most experience running end-to-end, regulatory-grade digital therapeutics (DTx) studies with purpose-built technology for faster recruitment, better retention, and greater diversity.

Fast, flexible, end-to-end diagnostic studies
All-in-one solution

Fast, flexible end-to-end diagnostic studies

Curebase is the only partner you need to run your study from start to finish with purpose-built technology for faster recruitment, greater diversity, and better patient experience.

The most comprehensive, tech-driven solution for real-world long term follow-up research.

The most comprehensive, tech-driven solution for real-world digital therapeutics research.

The most comprehensive, tech-driven solution for real-world diagnostics research

Leverage our best-in-class user experience, remote-first trial management services, and network of renowned PIs to reach patients anywhere.

Trial Management Services

  • Trial management
  • Data management
  • Submissions
  • Remote monitoring
  • Recruitment

Virtual & Hybrid Sites

  • Virtual PIs
  • Virtual Clinical Research Coordinators
  • Telemedicine staff
  • Home-based logistics management
  • Flexible mobile and site options

Clinical Trial Software

  • ePRO/eCOA
  • eConsent
  • Telemedicine
  • Site Portal
  • eSource
  • EDC and more
Let's work together

Chat with one of our digital therapeutics (DTx) study experts

Take the first step to more efficient and inclusive clinical trials.

1. Fill out this form
2. Schedule a time to meet
3. A member of our team will be in touch

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.